Search
for
Sort by
Research 271–300 of 1000+
- 5-Alpha reductase deficiency
- 5α-Reductase inhibitors in androgenetic alopecia
- Post-finasteride syndrome
- Men’s use of cosmetic surgery and the role of traditional masculinity ideologies
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Exploration of Therapeutic Ethno-Medicinal Plants used by Traditional Healers & Practitioners of Raichur District, Karnataka, India
- 424 Grey-Scale Penile Ultrasound Findings in Young Men With Erectile Dysfunction (ED) Who Used Finasteride for Androgenic Alopecia
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- BIOACTIVE SUBSTANCE OF MEDICINAL PLANTS EFFECTIVE AGAINST HAIR LOSS
- Clinical biochemistry of dihydrotestosterone
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Effects of polycystic ovary syndrome on health-related quality of life
- Gender effects in allergology – Secondary publications and update
- Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement
- An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment
- Androgen Treatment in Women
- Hormesis and medicine
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- PCOS in lesbian and heterosexual women treated with artificial donor insemination
- Cross sectional quality of life assessment in patients with androgenetic alopecia
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Low serum zinc concentration is associated with low serum testosterone but not erectile function
- 46, XY 5-Alpha Reductase Deficiency in a 36-Year-Old Phenotypic Female Patient